{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:46:13Z","timestamp":1770813973057,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700314"],"award-info":[{"award-number":["81700314"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07683-4","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:54:15Z","timestamp":1768276455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting osteopontin with gold nanoparticles for enhanced molecular imaging in Kawasaki disease: in-depth mechanistic study of STAT3 signaling in Col1 regulation"],"prefix":"10.1186","volume":"24","author":[{"given":"Junbo","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"1","key":"7683_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/INF.0000000000000914","volume":"35","author":"J-J Chen","year":"2016","unstructured":"Chen J-J, Ma X-J, Liu F, Yan W-L, Huang M-R, Huang M, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Disease J. 2016;35(1):7\u201312.","journal-title":"Pediatr Infect Disease J"},{"issue":"10","key":"7683_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2188\/jea.JE20190065","volume":"30","author":"L-p Xie","year":"2020","unstructured":"Xie L-p, Yan W-l, Huang M, Huang M-r, Chen S, Huang G-y, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol. 2020;30(10):429\u201335.","journal-title":"J Epidemiol"},{"issue":"3","key":"7683_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s42399-021-00775-w","volume":"3","author":"D Abraham","year":"2021","unstructured":"Abraham D, Kalyanasundaram S, Krishnamurthy K. Refractory Kawasaki Disease\u2014a challenge for the pediatrician. SN Compr Clin Med. 2021;3(3):855\u201360.","journal-title":"SN Compr Clin Med"},{"issue":"2","key":"7683_CR4","first-page":"100214","volume":"3","author":"Q Hu","year":"2022","unstructured":"Hu Q, Fang Z, Ge J, Li H. Nanotechnology for cardiovascular diseases. Innov. 2022;3(2):100214.","journal-title":"Innov"},{"issue":"16","key":"7683_CR5","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.7150\/thno.51419","volume":"11","author":"LBN Langer","year":"2021","unstructured":"Langer LBN, Hess A, Korkmaz Z, Tillmanns J, Reffert LM, Bankstahl JP, et al. Molecular imaging of fibroblast activation protein after myocardial infarction using the novel Radiotracer [68Ga]MHLL1. Theranostics. 2021;11(16):7755\u201366.","journal-title":"Theranostics"},{"issue":"2","key":"7683_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/CIRCRESAHA.120.315890","volume":"128","author":"M Nayor","year":"2021","unstructured":"Nayor M, Brown KJ, Vasan RS. The molecular basis of predicting atherosclerotic cardiovascular disease risk. Circul Res. 2021;128(2):287\u2013303.","journal-title":"Circul Res"},{"issue":"2","key":"7683_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/MNM.0b013e3283411c67","volume":"32","author":"R Kashyap","year":"2011","unstructured":"Kashyap R, Mittal BR, Bhattacharya A, Manojkumar R, Singh S. Exercise myocardial perfusion imaging to evaluate inducible ischaemia in children with Kawasaki disease. Nucl Med Commun. 2011;32(2):137\u201341.","journal-title":"Nucl Med Commun"},{"issue":"5","key":"7683_CR8","doi-asserted-by":"publisher","first-page":"C781","DOI":"10.1152\/ajpcell.00353.2020","volume":"319","author":"K Imanaka-Yoshida","year":"2020","unstructured":"Imanaka-Yoshida K, Tawara I, Yoshida T. Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis. Am J Physiology-Cell Physiol. 2020;319(5):C781\u201396.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"1","key":"7683_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1148\/radiol.11110040","volume":"262","author":"HS Su","year":"2012","unstructured":"Su HS, Nahrendorf M, Panizzi P, Breckwoldt MO, Rodriguez E, Iwamoto Y, et al. Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. Radiology. 2012;262(1):181\u201390.","journal-title":"Radiology"},{"issue":"7","key":"7683_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391\u2013405.","journal-title":"Nat Rev Rheumatol"},{"key":"7683_CR11","doi-asserted-by":"crossref","unstructured":"Abdelaziz Mohamed I, Gadeau A-P, Hasan A, Abdulrahman N, Mraiche F. Osteopontin: a promising therapeutic target in cardiac fibrosis. Cells. 2019;8(12).","DOI":"10.3390\/cells8121558"},{"issue":"4","key":"7683_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/ATVBAHA.118.311577","volume":"39","author":"ZSY Lok","year":"2019","unstructured":"Lok ZSY, Lyle AN, Arteriosclerosis. Thromb Vascular Biology. 2019;39(4):613\u201322.","journal-title":"Thromb Vascular Biology"},{"issue":"18","key":"7683_CR13","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","volume":"138","author":"K Shirakawa","year":"2018","unstructured":"Shirakawa K, Endo J, Kataoka M, Katsumata Y, Yoshida N, Yamamoto T, et al. IL (Interleukin)-10\u2013STAT3\u2013Galectin-3 axis is essential for Osteopontin-Producing reparative macrophage polarization after myocardial infarction. Circulation. 2018;138(18):2021\u201335.","journal-title":"Circulation"},{"key":"7683_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.biomaterials.2016.10.011","volume":"112","author":"H Qiao","year":"2017","unstructured":"Qiao H, Wang Y, Zhang R, Gao Q, Liang X, Gao L, et al. MRI\/optical dual-modality imaging of vulnerable atherosclerotic plaque with an osteopontin-targeted probe based on Fe3O4 nanoparticles. Biomaterials. 2017;112:336\u201345.","journal-title":"Biomaterials"},{"issue":"2","key":"7683_CR15","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1021\/acsnano.6b07842","volume":"11","author":"R Qiao","year":"2017","unstructured":"Qiao R, Qiao H, Zhang Y, Wang Y, Chi C, Tian J, et al. Molecular imaging of vulnerable atherosclerotic plaques in vivo with Osteopontin-Specific upconversion nanoprobes. ACS Nano. 2017;11(2):1816\u201325.","journal-title":"ACS Nano"},{"issue":"2","key":"7683_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00011-003-1225-1","volume":"53","author":"K Takahashi","year":"2004","unstructured":"Takahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, Murata H. Histopathological features of murine systemic vasculitis caused by Candida albicans extract ? An Animal model of Kawasaki disease. Inflamm Res. 2004;53(2):72\u20137.","journal-title":"Inflamm Res"},{"issue":"4","key":"7683_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1574-695X.1999.tb01313.x","volume":"24","author":"M Uchiyama","year":"1999","unstructured":"Uchiyama M, Ohno N, Miura NN, Adachi Y, Aizawa MW, Tamura H, et al. Chemical and immunochemical characterization of limulus factor G-activating substance OfCandidaspp. FEMS Immunol Med Microbiol. 1999;24(4):411\u201320.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"7683_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.addr.2016.09.006","volume":"113","author":"PU Atukorale","year":"2017","unstructured":"Atukorale PU, Covarrubias G, Bauer L, Karathanasis E. Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev. 2017;113:141\u201356.","journal-title":"Adv Drug Deliv Rev"},{"key":"7683_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jare.2021.12.011","volume":"41","author":"Y-J Jiang","year":"2022","unstructured":"Jiang Y-J, Chao C-C, Chang A-C, Chen P-C, Cheng F-J, Liu J-F, et al. Cigarette smoke-promoted increases in osteopontin expression attract mesenchymal stem cell recruitment and facilitate lung cancer metastasis. J Adv Res. 2022;41:77\u201387.","journal-title":"J Adv Res"},{"issue":"10","key":"7683_CR20","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"D Bobo","year":"2016","unstructured":"Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-Based medicines: A review of FDA-Approved materials and clinical trials to date. Pharm Res. 2016;33(10):2373\u201387.","journal-title":"Pharm Res"},{"issue":"1","key":"7683_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, Cao Y, Cao M, Wang Y, Cao Y, Gong T. Nanomedicine in cancer therapy. Signal Transduct Target Therapy. 2023;8(1):293.","journal-title":"Signal Transduct Target Therapy"},{"key":"7683_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","volume":"240","author":"Y-N Zhang","year":"2016","unstructured":"Zhang Y-N, Poon W, Tavares AJ, McGilvray ID, Chan WCW. Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination. J Controlled Release. 2016;240:332\u201348.","journal-title":"J Controlled Release"},{"issue":"50","key":"7683_CR23","doi-asserted-by":"publisher","first-page":"13319","DOI":"10.1002\/anie.201306306","volume":"52","author":"F Chen","year":"2013","unstructured":"Chen F, Ellison PA, Lewis CM, Hong H, Zhang Y, Shi S, et al. Chelator-Free synthesis of a Dual\u2010Modality PET\/MRI agent. Angew Chem Int Ed. 2013;52(50):13319\u201323.","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"7683_CR24","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1021\/mp3005885","volume":"10","author":"AJ Mieszawska","year":"2013","unstructured":"Mieszawska AJ, Mulder WJM, Fayad ZA, Cormode DP. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm. 2013;10(3):831\u201347.","journal-title":"Mol Pharm"},{"issue":"17","key":"7683_CR25","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term management of Kawasaki disease: A scientific statement for health professionals from the American heart association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"1","key":"7683_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/art.21699","volume":"55","author":"D Blockmans","year":"2006","unstructured":"Blockmans D, Ceuninck Ld, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Care Res. 2006;55(1):131\u20137.","journal-title":"Arthritis Care Res"},{"issue":"8","key":"7683_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/ard.2008.101816","volume":"68","author":"TA Bley","year":"2009","unstructured":"Bley TA, Geiger J, Jacobsen S, Wieben O, Markl M, Vaith P, et al. High-resolution MRI for assessment of middle meningeal artery involvement in giant cell arteritis. Ann Rheum Dis. 2009;68(8):1369\u201370.","journal-title":"Ann Rheum Dis"},{"key":"7683_CR28","doi-asserted-by":"crossref","unstructured":"Ozanne J, Lewis M, Schwenzer A, Kurian D, Brady J, Pritchard D, et al. Extracellular matrix complexity in biomarker studies: a novel assay detecting total serum tenascin-C reveals different distribution to isoform-specific assays. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1275361"},{"key":"7683_CR29","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.ijcha.2022.101149","volume":"43","author":"T Almas","year":"2022","unstructured":"Almas T, Haider R, Malik J, Mehmood A, Alvi A, Naz H, et al. Nanotechnology in interventional cardiology: A state-of-the-art review. IJC Heart Vasculature. 2022;43:101149.","journal-title":"IJC Heart Vasculature"},{"issue":"12","key":"7683_CR30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1177\/0022034515605270","volume":"94","author":"SR Rittling","year":"2015","unstructured":"Rittling SR, Singh R. Osteopontin in Immune-mediated diseases. J Dent Res. 2015;94(12):1638\u201345.","journal-title":"J Dent Res"},{"issue":"1","key":"7683_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.pharmtox.41.1.723","volume":"41","author":"DT Denhardt","year":"2001","unstructured":"Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol. 2001;41(1):723\u201349.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"7683_CR32","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.1038\/s41598-019-48748-3","volume":"9","author":"A-L Bailly","year":"2019","unstructured":"Bailly A-L, Correard F, Popov A, Tselikov G, Chaspoul F, Appay R, et al. In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci Rep. 2019;9(1):12890.","journal-title":"Sci Rep"},{"issue":"4","key":"7683_CR33","doi-asserted-by":"publisher","first-page":"042010","DOI":"10.1088\/1748-605X\/ad5484","volume":"19","author":"BK Sodipo","year":"2024","unstructured":"Sodipo BK, Kasim Mohammed Z. Advances in biodistribution of gold nanoparticles: the influence of size, surface charge, and route of administration. Biomed Mater. 2024;19(4):042010.","journal-title":"Biomed Mater"},{"key":"7683_CR34","doi-asserted-by":"publisher","first-page":"1544393","DOI":"10.3389\/fmed.2025.1544393","volume":"12","author":"FD Rodr\u00edguez-G\u00f3mez","year":"2025","unstructured":"Rodr\u00edguez-G\u00f3mez FD, Monferrer D, Penon O, Rivera-Gil P. Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks. Front Med. 2025;12:1544393.","journal-title":"Front Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07683-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:41:10Z","timestamp":1770648070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07683-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7683"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07683-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data supporting the findings of this study are publicly available from the following sources: ChIP-seq data for the Col1a1 enhancer can be accessed via the Cistrome database:\n                      \n                      ; ChIP-seq data for Stat3 enhancer binding are available through the JASPAR database:\n                      \n                      . All other relevant data and materials generated or analyzed during this study are available upon reasonable request from the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors confirm that they have no known competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}